Firebrick Pharma Limited
No trades
No trades
Compare with Firebrick Pharma Limited
−0.012 AUD
−3.06 M AUD
106.03 K AUD
223.99 M
Company info
Sector
Industry
CEO
Peter Laurence Molloy
Website
Headquarters
Melbourne
Founded
2012
IPO date
Jan 28, 2022
ISIN
AU0000197352
FIGI
BBG0140SS6M0
Identifiers
ISIN AU0000197352
Firebrick Pharma Ltd. is a pharmaceutical company, which engages in the development and commercialization of nasal spray treatment for the common cold based around the potential of povidone-iodine as an antimicrobial agent. The company was founded by Peter Laurence Molloy and Stephen Goodall on April 12, 2012 and is headquartered in Melbourne, Australia.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of FRE is 0.028 AUD — it hasn't changed in the past 24 hours. Watch Firebrick Pharma Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Firebrick Pharma Limited stocks are traded under the ticker FRE.
FRE stock has risen by 7.69% compared to the previous week, the month change is a −12.50% fall, over the last year Firebrick Pharma Limited has showed a −55.56% decrease.
FRE stock is 0.00% volatile and has beta coefficient of −0.23. Track Firebrick Pharma Limited stock price on the chart and check out the list of the most volatile stocks — is Firebrick Pharma Limited there?
Today Firebrick Pharma Limited has the market capitalization of 8.04 M, it has decreased by −3.70% over the last week.
Yes, you can track Firebrick Pharma Limited financials in yearly and quarterly reports right on TradingView.
FRE net income for the last half-year is −1.80 M AUD, while the previous report showed −1.26 M AUD of net income which accounts for 0.00% change. Track more Firebrick Pharma Limited financial stats to get the full picture.
No, FRE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Firebrick Pharma Limited EBITDA is −3.10 M AUD, and current EBITDA margin is −2.92 K%. See more stats in Firebrick Pharma Limited financial statements.
Like other stocks, FRE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Firebrick Pharma Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Firebrick Pharma Limited technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Firebrick Pharma Limited stock shows the sell signal. See more of Firebrick Pharma Limited technicals for a more comprehensive analysis.